APA (7th ed.) Citation

L, M., G, F., RM, G., G, C., S, F., MH, K., . . . S, M. (2017). Corrigendum: Acquired CYP19A1 amplification is an early specific mechanism of aromatase inhibitor resistance in ERα metastatic breast cancer. Nature genetics, 49(6), 970. https://doi.org/10.1038/ng0617-970b

Chicago Style (17th ed.) Citation

L, Magnani, et al. "Corrigendum: Acquired CYP19A1 Amplification Is an Early Specific Mechanism of Aromatase Inhibitor Resistance in ERα Metastatic Breast Cancer." Nature Genetics 49, no. 6 (2017): 970. https://doi.org/10.1038/ng0617-970b.

MLA (9th ed.) Citation

L, Magnani, et al. "Corrigendum: Acquired CYP19A1 Amplification Is an Early Specific Mechanism of Aromatase Inhibitor Resistance in ERα Metastatic Breast Cancer." Nature Genetics, vol. 49, no. 6, 2017, p. 970, https://doi.org/10.1038/ng0617-970b.